CAPTURE: A phase II randomised study to evaluate alpelisib plus fulvestrant versus capecitabine in oestrogen receptor-positive, HER2-negative advanced breast cancer patients with PIK3CA mutant circulating DNA

Link
https://hdl.handle.net/10137/12752
Subject
Advanced Breast Cancer
Title
CAPTURE: A phase II randomised study to evaluate alpelisib plus fulvestrant versus capecitabine in oestrogen receptor-positive, HER2-negative advanced breast cancer patients with PIK3CA mutant circulating DNA
Type of document
Interventional/Clinical trials research
Entity Type
Project

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/8fb0572f-c36c-46d3-a680-6973016dea79